In addition, the chronic phase was also characterized by changes in neuronal molecular markers indicative of axonal and synaptic damage (alterations in neurofilaments and PSD-95) and impaired neurotrophism (decreased BDNF levels), which were associated with memory impairment. Here, BDNF is linked to memory impairment.